Senseonics Holdings, Inc. (SENS)
USD 0.78
(5.32%)
USD 0.78
(5.32%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 3.09 Million USD | 13.39% |
| 2022 | 2.72 Million USD | 436.13% |
| 2021 | -811 Thousand USD | 95.33% |
| 2020 | -17.36 Million USD | 10.71% |
| 2019 | -19.44 Million USD | -138.74% |
| 2018 | -8.14 Million USD | -140.65% |
| 2017 | -3.38 Million USD | -932.01% |
| 2016 | -328 Thousand USD | -310.0% |
| 2015 | -80 Thousand USD | 0.0% |
| 2014 | - USD | -100.0% |
| 2013 | 12 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 FY | 3.09 Million USD | 13.39% |
| 2023 Q1 | 1.17 Million USD | 181.06% |
| 2023 Q4 | 298 Thousand USD | -11.04% |
| 2023 Q3 | 335 Thousand USD | -69.24% |
| 2023 Q2 | 1.08 Million USD | -7.08% |
| 2022 Q2 | 619 Thousand USD | -18.12% |
| 2022 Q3 | 414 Thousand USD | -33.12% |
| 2022 Q4 | 417 Thousand USD | 0.72% |
| 2022 Q1 | 756 Thousand USD | -8.25% |
| 2022 FY | 2.72 Million USD | 436.13% |
| 2021 Q3 | 527 Thousand USD | 209.11% |
| 2021 Q2 | -483 Thousand USD | 61.24% |
| 2021 Q4 | 824 Thousand USD | 56.36% |
| 2021 Q1 | -1.24 Million USD | -417.86% |
| 2021 FY | -811 Thousand USD | 95.33% |
| 2020 Q1 | 699 Thousand USD | 161.15% |
| 2020 Q4 | 392 Thousand USD | -25.48% |
| 2020 FY | -17.36 Million USD | 10.71% |
| 2020 Q2 | 2.57 Million USD | 268.53% |
| 2020 Q3 | 526 Thousand USD | -79.58% |
| 2019 Q1 | -3.34 Million USD | 26.64% |
| 2019 FY | -19.44 Million USD | -138.74% |
| 2019 Q4 | -1.14 Million USD | 94.18% |
| 2019 Q3 | -19.63 Million USD | -138.13% |
| 2019 Q2 | -8.24 Million USD | -146.86% |
| 2018 Q2 | -4.98 Million USD | -92.92% |
| 2018 Q1 | -2.58 Million USD | -1096.3% |
| 2018 Q3 | -3.31 Million USD | 33.6% |
| 2018 Q4 | -4.55 Million USD | -37.55% |
| 2018 FY | -8.14 Million USD | -140.65% |
| 2017 Q3 | -362 Thousand USD | 68.05% |
| 2017 FY | -3.38 Million USD | -932.01% |
| 2017 Q4 | -216 Thousand USD | 40.33% |
| 2017 Q2 | -1.13 Million USD | -31.74% |
| 2017 Q1 | -860 Thousand USD | 4.44% |
| 2016 Q2 | -236 Thousand USD | -206.49% |
| 2016 Q1 | -77 Thousand USD | -413.33% |
| 2016 Q3 | -492 Thousand USD | -108.47% |
| 2016 Q4 | -900 Thousand USD | -82.93% |
| 2016 FY | -328 Thousand USD | -310.0% |
| 2015 FY | -80 Thousand USD | 0.0% |
| 2015 Q1 | - USD | -100.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q3 | -10.92 Million USD | 0.0% |
| 2015 Q4 | -15 Thousand USD | 99.86% |
| 2014 FY | - USD | -100.0% |
| 2014 Q3 | 15 Thousand USD | 0.0% |
| 2014 Q4 | 23 Thousand USD | 53.33% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2013 FY | 12 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Perspective Therapeutics, Inc. | 1.63 Million USD | -89.168% |
| Electromed, Inc. | 41.72 Million USD | 92.592% |
| Catheter Precision, Inc. | 412 Thousand USD | -650.243% |
| Xtant Medical Holdings, Inc. | 55.46 Million USD | 94.427% |